ABBOTT LABORATORIES 10-Q filing
Filed 2026-04-29 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-028357
- Form type
- 10-Q
- CIK
- 0000001800
- Primary document
- https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/abt-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ABBOTT LABORATORIES.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $11.2B | - | - |
| Cost Of Revenue | $4.9B | - | - |
| Operating Income | $1.3B | - | - |
| Net Income | $1.1B | - | - |
| Eps Basic | 0.62 | - | - |
| Eps Diluted | 0.61 | - | - |
| Cash And Equivalents | $6.8B | - | - |
| Total Assets | $110.4B | - | - |
| Shareholders Equity | $52.1B | - | - |
| Operating Cash Flow | $1.3B | - | - |
| Capital Expenditures | $399.0M | - | - |